These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 9131328)

  • 1. Outbreak of Escherichia coli O157:H7 infection in a large family.
    Ludwig K; Ruder H; Bitzan M; Zimmermann S; Karch H
    Eur J Clin Microbiol Infect Dis; 1997 Mar; 16(3):238-41. PubMed ID: 9131328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic comparisons and Shiga toxin production among Escherichia coli O157:H7 isolates from a day care center outbreak and sporadic cases in southeastern Wisconsin.
    Gouveia S; Proctor ME; Lee MS; Luchansky JB; Kaspar CW
    J Clin Microbiol; 1998 Mar; 36(3):727-33. PubMed ID: 9508303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A clinical and bacteriological study of children suffering from haemolytic uraemic syndrome in Tucuman, Argentina.
    Miceli S; Jure MA; de Saab OA; de Castillo MC; Rojas S; de Holgado AP; de Nader OM
    Jpn J Infect Dis; 1999 Apr; 52(2):33-7. PubMed ID: 10816611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of verocytotoxin from stool and serological testing of patients with diarrhea caused by Escherichia coli O157 : H7.
    Yamada S; Matsushita S; Kai A; Sasaki M; Tsuji A; Kanemitsu T; Yamashita N; Anzai E; Kudoh Y
    Microbiol Immunol; 1993; 37(2):111-8. PubMed ID: 8502176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Desperately seeking diarrhoea: outbreak of haemolytic uraemic syndrome caused by emerging sorbitol-fermenting shiga toxin-producing Escherichia coli O157:H-, Germany, 2009.
    Nielsen S; Frank C; Fruth A; Spode A; Prager R; Graff A; Plenge-Bönig A; Loos S; Lütgehetmann M; Kemper MJ; Müller-Wiefel DE; Werber D
    Zoonoses Public Health; 2011 Dec; 58(8):567-72. PubMed ID: 21824358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haemolytic uraemic syndrome and Shiga toxin-producing Escherichia coli infection in children in France. The Société de Néphrologie Pédiatrique.
    Decludt B; Bouvet P; Mariani-Kurkdjian P; Grimont F; Grimont PA; Hubert B; Loirat C
    Epidemiol Infect; 2000 Apr; 124(2):215-20. PubMed ID: 10813145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome.
    Tarr PI; Gordon CA; Chandler WL
    Lancet; 2005 Mar 19-25; 365(9464):1073-86. PubMed ID: 15781103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence, virulence profiles, and clinical significance of Shiga toxin-negative variants of enterohemorrhagic Escherichia coli O157 infection in humans.
    Friedrich AW; Zhang W; Bielaszewska M; Mellmann A; Köck R; Fruth A; Tschäpe H; Karch H
    Clin Infect Dis; 2007 Jul; 45(1):39-45. PubMed ID: 17554698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Escherichia coli O157:H7 and O157:H(-) strains that do not produce Shiga toxin: phenotypic and genetic characterization of isolates associated with diarrhea and hemolytic-uremic syndrome.
    Schmidt H; Scheef J; Huppertz HI; Frosch M; Karch H
    J Clin Microbiol; 1999 Nov; 37(11):3491-6. PubMed ID: 10523540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An outbreak due to enterohaemorrhagic Escherichia coli O157:H7 in a children day care centre characterized by person-to-person transmission and environmental contamination.
    Reida P; Wolff M; Pöhls HW; Kuhlmann W; Lehmacher A; Aleksić S; Karch H; Bockemühl J
    Zentralbl Bakteriol; 1994 Nov; 281(4):534-43. PubMed ID: 7727902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Humoral immune responses to Shiga-like toxins and Escherichia coli O157 lipopolysaccharide in hemolytic-uremic syndrome patients and healthy subjects.
    Greatorex JS; Thorne GM
    J Clin Microbiol; 1994 May; 32(5):1172-8. PubMed ID: 8051241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shiga toxin-associated hemolytic uremic syndrome and thrombotic thrombocytopenic purpura: distinct mechanisms of pathogenesis.
    Tarr PI
    Kidney Int Suppl; 2009 Feb; (112):S29-32. PubMed ID: 19180128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Saliva IgM and IgA are a sensitive indicator of the humoral immune response to Escherichia coli O157 lipopolysaccharide in children with enteropathic hemolytic uremic syndrome.
    Ludwig K; Grabhorn E; Bitzan M; Bobrowski C; Kemper MJ; Sobottka I; Laufs R; Karch H; Müller-Wiefel DE
    Pediatr Res; 2002 Aug; 52(2):307-13. PubMed ID: 12149511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Verocytotoxin-producing Escherichia coli infection in household members of children with hemolytic-uremic syndrome in The Netherlands.
    Heuvelink AE; Van de Kar NC; Van Der Velden TJ; Chart H; Monnens LA
    Pediatr Infect Dis J; 1999 Aug; 18(8):709-14. PubMed ID: 10462341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemolytic-Uremic Syndrome and Escherichia coli O121 at a Lake in Connecticut, 1999.
    McCarthy TA; Barrett NL; Hadler JL; Salsbury B; Howard RT; Dingman DW; Brinkman CD; Bibb WF; Cartter ML
    Pediatrics; 2001 Oct; 108(4):E59. PubMed ID: 11581467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of O157 versus non-O157 Shiga toxin-producing Escherichia coli infections in Minnesota, 2000-2006.
    Hedican EB; Medus C; Besser JM; Juni BA; Koziol B; Taylor C; Smith KE
    Clin Infect Dis; 2009 Aug; 49(3):358-64. PubMed ID: 19548834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune response to Escherichia coli O157:H7 in hemolytic uremic syndrome following salmonellosis.
    Flores FX; Jabs K; Thorne GM; Jaeger J; Linshaw MA; Somers MJ
    Pediatr Nephrol; 1997 Aug; 11(4):488-90. PubMed ID: 9260252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ongoing haemolytic uraemic syndrome (HUS) outbreak caused by sorbitol-fermenting (SF) Shiga toxin-producing Escherichia coli (STEC) O157, Germany, December 2016 to May 2017.
    Vygen-Bonnet S; Rosner B; Wilking H; Fruth A; Prager R; Kossow A; Lang C; Simon S; Seidel J; Faber M; Schielke A; Michaelis K; Holzer A; Kamphausen R; Kalhöfer D; Thole S; Mellmann A; Flieger A; Stark K
    Euro Surveill; 2017 May; 22(21):. PubMed ID: 28597831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization and epidemiologic subtyping of Shiga toxin-producing Escherichia coli strains isolated from hemolytic uremic syndrome and diarrhea cases in Argentina.
    Rivas M; Miliwebsky E; Chinen I; Roldán CD; Balbi L; García B; Fiorilli G; Sosa-Estani S; Kincaid J; Rangel J; Griffin PM;
    Foodborne Pathog Dis; 2006; 3(1):88-96. PubMed ID: 16602984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion.
    Ake JA; Jelacic S; Ciol MA; Watkins SL; Murray KF; Christie DL; Klein EJ; Tarr PI
    Pediatrics; 2005 Jun; 115(6):e673-80. PubMed ID: 15930195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.